Komori
Bml (4694) · RiskRestated

Profit pressure from higher specimen transportation and other costs

First written in FY2018-Q3. 5 of 6 entries say "Restated". Latest entry: FY2023-Q3.

6entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q3 – FY2023-Q32018: 220182019: 120192020: 120202021: 020212022: 120222023: 1
Same theme, other companies
Medical business profit pressure from higher specimen transportation and other costsA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」

    It states that there were no material changes to the previously disclosed profit pressure from higher specimen transportation and other costs.
  2. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」

    It states that there were no material changes to the previously disclosed profit pressure from higher specimen transportation and other costs.
  3. FY2020-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」

    It states that there were no material changes to the previously disclosed profit pressure from higher specimen transportation and other costs.
  4. FY2019-Q3RestatedAnnual report

    「During the cumulative third quarter of the fiscal year, there were no material changes in the financial position, operating results, or cash flow situation, including any abnormal fluctuations, or in the business and other risks described in the annual securities report for the previous fiscal year. There were also no material events or other matters of concern.」

    It states that there were no material changes to the previously disclosed profit pressure from higher specimen transportation and other costs.
  5. FY2019-Q2RestatedAnnual report

    「During the cumulative second quarter of the current fiscal year, there were no material changes in the financial position, operating results or cash flow, including any abnormal fluctuations, or in the “Business and Other Risks” described in the annual securities report for the previous fiscal year. There are also no material events or similar matters.」

    It states that there were no material changes to the previously disclosed profit pressure from higher specimen transportation and other costs.
  6. FY2018-Q3First statedAnnual report

    「In terms of earnings, expenses increased because the company actively invested in personnel and facilities to improve quality and services, improved the treatment of non-regular employees to stabilize employment and for other purposes, and incurred higher costs related to transporting specimens, among others.」

    It states that specimen transportation and other costs actually increased and, together with investment in personnel and facilities and improved treatment of non-regular employees, were factors driving higher costs affecting profits.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Bml's next results are scheduled for 2026-11-11. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.